This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06865/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB06865/identifier/pdb/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB06865/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06865/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB06865/identifier/drugbank/

Statements

Subject Item
n2:DB06865
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB06865 n14:DB06865
dcterms:title
6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID
adms:identifier
n7:DB06865 n8:166 n9:395027 n10:448123 n11:99443336
n3:IUPAC-Name
n4:271B5962-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5968-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5967-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5964-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5965-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5966-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5960-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B595E-363D-11E5-9242-09173F13E4C5 n4:271B5961-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B595F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B596E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B596F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5969-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B596A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B596C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B596B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B596D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5974-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5976-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5977-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5973-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5972-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5975-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5963-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5970-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5971-363D-11E5-9242-09173F13E4C5